Compounding pharmacies are asked two different questions by two different sets of rules: what the compounding chapter requires of the preparation, and what the sterilization standards require of anything that gets sterilized along the way. This guide maps the first onto the second — category by category, from nonsterile Level A work to hazardous drugs and sterile compounding — and shows which records an inspector will reconstruct from your files. It is written for pharmacy managers, compounding supervisors and quality leads who already know the workflow and need the interface documented, not simplified.
If the item you sterilize is a wrapped load of glassware or utensils rather than a preparation, the same monitoring logic applies: a
24-hour self-contained biological indicator covers the spore test and an indicator tape covers the package mark, while the field definitions are in sterilization monitoring terms for BI, CI, PCD and load release.
Quick facts
- USP <795> sets standards for compounding quality nonsterile preparations; USP <797> covers sterile compounding; USP <800> covers handling of hazardous drugs.
- <800> became compendially applicable on 1 November 2023; its original official date was 1 December 2019.
- <795> and <800> do not set a spore-test frequency. The biological indicator obligation attaches to the sterilization standard and to the regulator that governs the site, not to the compounding chapter.
- Canada is not covered by USP directly. Provincial colleges implement NAPRA model standards, which were adapted from standards first developed in Quebec and based on USP <795>.
- Records are the deliverable. Master formulation, compounding, deactivation and cleaning, engineering-control verification, sterilizer cycle data and indicator results are what an inspection actually tests.
What each chapter actually governs
USP <795>: nonsterile preparations
USP describes <795> as providing standards for compounding quality nonsterile preparations, and frames the risk in clinical terms: a compounded medication made without standards "may be sub-potent, super potent or contaminated," exposing patients to adverse events. That is the scope you should quote when someone asks why a nonsterile cream deserves a written procedure — the chapter exists because dose accuracy and microbial control are both failure modes.
USP <800>: hazardous drugs
USP <800> is the handling standard rather than a preparation standard. Its own summary states that the chapter "provides standards for safe handling of hazardous drugs to minimize the risk of exposure to healthcare personnel, patients and the environment," and lists the requirement categories as:
- responsibilities of personnel handling hazardous drugs
- facility and engineering controls
- procedures for deactivating, decontaminating and cleaning
- spill control
- documentation
The chapter applies "to all healthcare personnel who receive, prepare, administer, transport or otherwise come in contact with hazardous drugs and all the environments in which they are handled." Note the breadth — receiving and transport are in scope, which is why loading dock and housekeeping staff end up in the training matrix.
What counts as hazardous is set outside USP. Per USP's page, NIOSH considers a drug hazardous if it exhibits one or more of the following in humans or animals: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or structure and toxicity profiles of new drugs that mimic existing hazardous drugs. USP's page records that CDC published the NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 on 23 December 2024, and USP and NIOSH ran a joint webinar on the update in January 2025.
USP <797>: sterile compounding
<797> is the chapter that brings sterile processing into a compounding pharmacy's scope, and USP's site records it becoming official on 1 November 2023. The distinction matters for this article: <795> and <800> generate cleaning, deactivation and documentation duties, while <797> is where "the item was sterilized" becomes a process you have to control and evidence.Which category is your preparation in?
The four columns below are the ones auditors move between: the category fixes the environment, the environment fixes the cleaning and monitoring duty, and the duty fixes what must be written down.
| Compounding category | Environment required | Cleaning, sterilization and monitoring duty | Records that carry the evidence |
|---|---|---|---|
| Nonsterile, simple or moderate (Level A in the Alberta adaptation of the NAPRA standard) | Separate space designated for compounding; cleanable surfaces; hand hygiene at entry | Cleaning of surfaces and equipment on a defined schedule; reusable utensils cleaned and dried before storage. Sterilization is not implied by this category | Cleaning log with date, area, agent, contact time, initials; equipment list; training record |
| Nonsterile, complex (Level B) | Separate well-ventilated room, larger workspace, conditions that allow little or no interruption | As above plus ventilation controls; containment device when certain powders, aromatic products or hazardous products are handled | Room and ventilation checks; containment device records; batch record per preparation |
| Hazardous nonsterile (Level C: NIOSH Group 1, WHMIS health hazards, or routine large-quantity Group 2 and 3 APIs) | Separate room, well ventilated with appropriate air exchange and negative pressure; appropriate containment primary engineering control (C-PEC) | Deactivate, decontaminate and clean the C-PEC work surface before starting a different compound; hazardous waste stream; spill kit and spill procedure | C-PEC surface deactivation log; engineering-control verification report; spill and incident reports with follow-up |
| Sterile compounding (USP <797>) | Designated clean areas with the classification the chapter requires for the risk level | Sterilization of equipment and components controlled as a validated process; physical, chemical and biological monitoring as the sterilization standard requires | Sterilizer cycle records, indicator results, load release, deviation and recall record |
| Reusable instruments and utensils (dental, clinic, laboratory) | Decontamination area separated from clean assembly | Cleaning verification, packaging, sterilization and load release per the sterilization standard adopted for that device type | Instrument log, cycle parameters, indicator results, operator and verifier |
Two rows in that table make people uncomfortable, and they are the two that matter. First, cleaning is not sterilization: a Level A nonsterile operation that wipes a spatula has not sterilized anything, and writing "sterilized" on the log is a documentation defect, not a shortcut. Second, a Level C operation can have perfect containment and still fail an inspection on documentation, because <800> lists documentation as a requirement category in its own right.

Where sterilization monitoring actually attaches
Monitoring answers a narrower question than most people assume: did this cycle, in this chamber, under these conditions, achieve the specified lethality? Each instrument in the monitoring chain answers a different part of that question, and none of them substitutes for the others.
| Monitoring element | What it actually evidences | Typical trigger | Record field it creates |
|---|---|---|---|
| Physical parameters (time, temperature, pressure, and for some cycles humidity or concentration) | That the machine ran the cycle you selected | Every cycle | Cycle number, load ID, set point, actual readings, printout or data log |
| Chemical indicator, Class 1 (process indicator, such as indicator tape) | That the package saw the process — it distinguishes processed from unprocessed | Every package | Indicator present and read; result; initials |
| Chemical indicator, Class 2 (Bowie-Dick type test) | That air removal and steam penetration worked in an empty or test chamber | Start of the operating day or shift, per the standard in force | Test date, result, corrective action if failed |
| Chemical indicator, integrator classes (4, 5, 6) | That critical cycle variables reached the specified range inside the pack | Every load, per the standard or the site's procedure | Indicator class, lot, reading, interpretation |
| Biological indicator (spore test, ISO 11138 series) | That the cycle killed a known resistant population — the closest available evidence of lethality | At a frequency set by the sterilization standard and the regulator, not by the compounding chapter | Lot number, expiry, incubation start, result, reader ID, release decision |
| Process challenge device (PCD) | That the challenge was placed where the load is hardest to penetrate | Each monitored cycle where a PCD is specified | PCD type, position in chamber, result |
The practical consequence for a compounding pharmacy is that the monitoring obligation is inherited. If you sterilize glassware, filtration housings, or reusable utensils, the frequency and method come from the sterilization standard that applies to that process — for moist heat that means the requirements of the ISO 17665 series, with indicators specified in the ISO 11138 (biological) and ISO 11140 (chemical) series — plus whatever your provincial regulator or accreditation body has adopted. The compounding chapter tells you the item must be clean and, where required, sterile; it does not tell you how often to run a spore test.
Where a site does run biological indicators, the record has to survive without the person who wrote it. That means lot number and expiry, incubation conditions, reader identity, and the person who released the load. A spore result you can file and a process mark you can read on a pouch are the minimum most inspectors ask to see, and both are consumables decisions as much as documentation decisions.
Is USP <800> the same as the Canadian requirement?
No, and the distinction is not cosmetic. USP chapters are United States compendial standards. In Canada, compounding requirements reach pharmacy practice through provincial regulatory authorities, and the common technical basis is the NAPRA suite of model standards — non-hazardous sterile, hazardous sterile, and nonsterile — whose implementation NAPRA states is "under the authority of the respective provincial, territorial, or Canadian Forces pharmacy regulatory bodies," each with its own implementation process.
The provenance chain is documented in the provincial adaptations themselves. The Alberta College of Pharmacy's standards state that the NAPRA model standards were "adapted from standards originally developed by the Ordre des Pharmaciens du Quebec, which are in turn based on General Chapter <795> of the United States Pharmacopeia – National Formulary (USP–NF) in effect in the United States since 2004." So the technical lineage is real, while the legal instrument is provincial.
| Element | United States | Canada |
|---|---|---|
| Instrument that binds the pharmacy | USP general chapters, enforced through state boards of pharmacy and accreditation | Provincial college standards, commonly built on NAPRA model standards |
| Hazardous drug list | NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 | Same NIOSH list is used as the hazard reference in the NAPRA-based standards; WHMIS classification also applies |
| Nonsterile risk tiers | Chapter <795> definitions of simple, moderate and complex | Provincial adaptations assign levels; the Alberta document maps Level A, B and C onto the <795> definitions and NIOSH groups |
| Containment language | <800> facility and engineering controls, including C-PEC | Level C requirements: separate room, negative pressure, appropriate air exchange, appropriate containment device |
| Cleaning language | <800> deactivating, decontaminating and cleaning | Same three verbs; the Alberta text requires C-PEC surfaces to be deactivated, decontaminated and cleaned before a different compound |
| Documentation | <800> lists documentation as a requirement category | Incidents must be documented and followed up to prevent recurrence |
Ontario adds a useful data point for anyone comparing jurisdictions: the college frames compounding as a controlled act within the scope of practice of pharmacists and pharmacy technicians, and places the duty on the designated manager or department head to ensure the pharmacy has the resources to compound "a preparation of good quality in a safe and appropriate manner," naming knowledge of the environment, training of personnel, policies, procedures and quality assurance processes, and standards for facilities and equipment.

What an inspection reconstructs
Inspections do not read your policy binder; they pick a preparation and walk backwards. The five questions below account for most of the document requests in a compounding review, and each one lands on a specific record.
- Was this preparation authorized? Master formulation record, with components, quantities, beyond-use date basis and the person who approved it.
- Did the person who made it know how? Training and competency record tied to the specific preparation type, not a generic orientation certificate.
- Was the environment controlled on that day? Cleaning and deactivation logs; engineering-control verification; temperature, pressure and air-exchange evidence where the level requires it.
- Was the item that touched the preparation clean, and sterile if it had to be? Cleaning verification, then sterilization records: cycle data, chemical indicator result, biological indicator result where used, and the release decision.
- Did anything go wrong, and what changed? Incident and spill reports with the follow-up action, plus the corrective action record that closed it.
Two of those five are sterilizer records, which is why a pharmacy with a small autoclave in the back room needs the same discipline as a clinic: a cycle log that a second person can audit is far less work to build than to reconstruct.
Sources
- USP General Chapter <795>: Pharmaceutical Compounding – Nonsterile Preparations
- USP General Chapter <797>: Pharmaceutical Compounding – Sterile Preparations
- USP: Hazardous Drugs — Handling in Healthcare Settings (<800>)
- USP Compounding Compendium
- NIOSH List of Hazardous Drugs in Healthcare Settings, 2024 (PDF)
- CDC NIOSH: hazardous drugs in healthcare
- OSHA: hazardous drugs
- OSHA 29 CFR 1910.1030, Bloodborne Pathogens
- NAPRA: Model Standards for Pharmacy Compounding of Non-sterile Preparations
- NAPRA: Guidance Document for Pharmacy Compounding of Non-sterile Preparations
- Alberta College of Pharmacy: Standards for pharmacy compounding of non-sterile preparations (PDF)
- Ontario College of Pharmacists: Compounding
- Public Health Ontario: Infection Prevention and Control
- Ontario Occupational Health and Safety Act
- US EPA 40 CFR Part 63 Subpart O: ethylene oxide commercial sterilization
- CliniEco Medical: sterilization monitoring collection
Related Reading
- Does USP 797 apply in Canada? Provincial enforcement of sterile compounding standards
- Biological indicator record keeping in Canada versus the US
- Cleaning and disinfection SOP for a pharmacy sterile compounding room
Frequently Asked Questions
Do USP 795 and USP 800 require biological indicators?
No. Neither chapter sets a spore-test frequency. Chapter 795 governs nonsterile preparation quality and Chapter 800 governs hazardous drug handling, including deactivation, decontamination, cleaning and documentation. If a pharmacy sterilizes equipment or components, the biological indicator requirement comes from the sterilization standard applied to that process and from the regulator or accreditation body that governs the site.
Is USP 800 legally required in Canada?
Not as such. USP chapters are United States compendial standards. Canadian pharmacies are governed by their provincial college, and the common technical basis is the NAPRA model standards, which were adapted from Quebec standards that were themselves based on USP 795. The practical content overlaps heavily, but the binding instrument is provincial.
Does a compounding pharmacy need a Class 1 chemical indicator on every package?
A Class 1 process indicator is there to separate processed from unprocessed packages, which is why it is applied to the outside of every package rather than sampled. If your packaging process does not use one, the load record has to carry that distinction another way, and that gap is easy to find in an inspection.
What is the difference between deactivation, decontamination and cleaning?
They are sequential steps with different targets. Deactivation renders the hazardous residue inactive, decontamination removes hazardous residue, and cleaning removes soil. The Alberta adaptation of the NAPRA standard requires all three on C-PEC work surfaces before a different compound is started, which is why the log has to record the sequence and not just "wiped down."
How long do compounding and sterilization records need to be kept?
Retention is set by the regulator, not by the chapter. Provincial colleges specify retention periods for compounding records, and sterilization records generally follow the facility or professional standard in force — for example, log books in reprocessing settings are commonly held for a decade or longer. Confirm the number with your college and write it into the document control procedure.
Can a sterile compounding site use the same sterilizer as the instrument room?
Physical separation of clean and dirty flows is the controlling principle, and loading a nonsterile instrument load into the same chamber as sterile components creates a documentation and contamination question that most quality systems answer by keeping them apart. Where sharing is unavoidable, the sterilization records must show the load segregation and the release decision for each load separately.
What is the smallest useful improvement a small pharmacy can make?
Add the release decision to the sterilizer log: who released the load, on what evidence, at what time. Most incomplete records fail on that field rather than on the cycle data, because the cycle data comes from the machine and the release decision comes from a person.
Two of the three records above are generated at the bench, and the third is generated at the sterilizer. If you want the printable versions of the cycle and indicator fields before you rewrite your own, the compliance log centre has the templates, and wholesale pricing for clinics and pharmacies covers the consumables side when the procedure is settled. Questions about which monitoring format fits your sterilizer type go to a sterilization compliance specialist, and a five-pack of biological indicators for a trial load is available through the 24-hour biological indicator 25-pack. Reselling? become a distributor.
CliniEco Medical supplies sterilization monitoring and infection control consumables in Canada under MDEL #35334. This article describes published standards and does not constitute compounding, pharmacy or legal advice; follow your provincial college and the sterilization standard adopted at your site.